Therapeutic strategies in dementia disordersFERRIS, S. H.Acta neurologica Scandinavica. Supplementum. 1990, Vol 82, Num 129, pp 23-26, issn 0065-1427, 4 p.Conference Paper

Scales for the assessment of Alzheimer's diseaseKLUGER, A; FERRIS, S. H.The Psychiatric clinics of North America. 1991, Vol 14, Num 2, pp 309-326, issn 0193-953X, 18 p.Article

Hypersensitivity to scopolamine in the elderlyFLICKER, C; FERRIS, S. H; SERBY, M et al.Psychopharmacologia. 1992, Vol 107, Num 2-3, pp 437-441, issn 0033-3158Article

LESSONS LEARNED IN THE USE OF VOLUMETRIC MRI IN THERAPEUTIC TRIALS IN ALZHEIMER'S DISEASE: THE ALZHEMED^TM (TRAMIPROSATE) EXPERIENCESAUMIER, D; AISEN, P. S; HAINE, D et al.The Journal of nutrition, health & aging. 2009, Vol 13, Num 4, pp 370-372, issn 1279-7707, 3 p.Article

Validity and reliability of the Alzheimer's Disease Cooperative Study: Clinical Global Impression of ChangeSCHNEIDER, L. S; OLIN, J. T; DOODY, R. S et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp S22-S32, issn 0893-0341, SUP2Article

Quantitative EEG correlates of cognitive deterioration in the elderlyPRICHEP, L. S; JOHN, E. R; FERRIS, S. H et al.Neurobiology of aging. 1994, Vol 15, Num 1, pp 85-90, issn 0197-4580Article

Impaired facial recognition memory in aging and dementiaFLICKER, C; CROOK, T; FERRIS, S. H et al.Alzheimer disease and associated disorders. 1990, Vol 4, Num 1, pp 43-54, issn 0893-0341, 12 p.Article

Equivalent spatial-rotation deficits in normal aging and Alzheimer's diseaseFLICKER, C; FERRIS, S. H; CROOK, T et al.Journal of clinical and experimental neuropsychology. 1988, Vol 10, Num 4, pp 387-399, issn 0168-8634Article

Behavioral symptoms in Alzheimer's disease: phenomenology and treatmentREISBERG, B; BORENSTEIN, J; SALOB, S. P et al.The Journal of clinical psychiatry. 1987, Vol 48, Num 5, pp 9-15, issn 0160-6689Article

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's diseaseDE LEON, M. J; FERRIS, S. H; GEORGE, A. E et al.Journal of cerebral blood flow and metabolism. 1983, Vol 3, Num 3, pp 391-394, issn 0271-678XArticle

Mild cognitive impairment in the elderly : predictors of dementiaFLICKER, C; FERRIS, S. H; REISBERG, B et al.Neurology. 1991, Vol 41, Num 7, pp 1006-1009, issn 0028-3878Article

Dietary treatment of Alzheimeŕs type senile dementiaREISBERG, B; FERRIS, S. H; GERSHON, S et al.Aging (New York). 1984, Vol 26, pp 243-255, issn 0361-0179Article

A two-year longitudinal study of cognitive function in normal aging and Alzheimer's diseaseFLICKER, C; FERRIS, S. H; REISBERG, B et al.Journal of geriatric psychiatry and neurology. 1993, Vol 6, Num 2, pp 84-96, issn 0891-9887Article

A longitudinal study of cognitive function in elderly persons with subjective memory complaintsFLICKER, C; FERRIS, S. H; REISBERG, B et al.Journal of the American Geriatrics Society. 1993, Vol 41, Num 10, pp 1029-1032, issn 0002-8614Article

Scopolamine effects on memory, language, visuospatial praxis and psychomotor speedFLICKER, C; SERBY, M; FERRIS, S. H et al.Psychopharmacologia. 1990, Vol 100, Num 2, pp 243-250, issn 0033-3158Article

Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliabilityMONTEIRO, I. M; BOKSAY, I; AUER, S. R et al.European psychiatry. 2001, Vol 16, pp 5s-24s, issn 0924-9338, SUP1Conference Paper

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's diseaseDE LEON, M. J; GEORGE, A. E; INCE, C et al.Neurobiology of aging. 1997, Vol 18, Num 1, pp 1-11, issn 0197-4580Article

The Spanish instrument protocol : Design and implementation of a study to evaluate treatment efficacy instruments for Spanish-speaking patients with Alzheimer's diseaseSANO, M; MACKELL, J. A; SCHITTINI, M et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp S57-S64, issn 0893-0341, SUP2Article

Assessing cognition in Alzheimer disease researchFERRIS, S. H; KLUGER, A.Alzheimer disease and associated disorders. 1997, Vol 11, pp 45-49, issn 0893-0341, SUP6Conference Paper

A double-blind, placebo-controlled crossover study of ganglioside GM₁ treatment for Alzheimer's diseaseFLICKER, C; FERRIS, S. H; KALKSTEIN, D et al.The American journal of psychiatry. 1994, Vol 151, Num 1, pp 126-129, issn 0002-953XArticle

Hippocampal atrophy in normal aging : an association with recent memory impairmentGOLOMB, J; DE LEON, M. J; KLUGER, A et al.Archives of neurology (Chicago). 1993, Vol 50, Num 9, pp 967-973, issn 0003-9942Article

Alzheimer's disease: longitudinal CT studies of ventricular changeDE LEON, M. J; GEORGE, A. E; REISBERG, B et al.American journal of neuroradiology. 1989, Vol 10, Num 2, pp 371-376, issn 0195-6108Article

Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trialDOODY, R. S; FERRIS, S. H; SALLOWAY, S et al.Neurology. 2009, Vol 72, Num 18, pp 1555-1561, issn 0028-3878, 7 p.Article

A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials : Overview and general resultsFERRIS, S. H; MACKELL, J. A; GRUNDMAN, M et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp S1-S12, issn 0893-0341, SUP2Article

Development of cognitive instruments for use in clinical trials of antidementia drugs : Additions to the Alzheimer's disease assessment scale that broaden its scopeMOHS, R. C; KNOPMAN, D; THAL, L. J et al.Alzheimer disease and associated disorders. 1997, Vol 11, pp S13-S21, issn 0893-0341, SUP2Article